152 related articles for article (PubMed ID: 36435219)
1. Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling.
Liu S; Chen X; Huang K; Xiong X; Shi Y; Wang X; Pan X; Cong Y; Sun Y; Ge L; Xu J; Jia X
Exp Cell Res; 2023 Jan; 422(2):113438. PubMed ID: 36435219
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
Huang K; Chen X; Geng Z; Xiong X; Cong Y; Pan X; Liu S; Ge L; Xu J; Jia X
Funct Integr Genomics; 2023 Mar; 23(2):110. PubMed ID: 36995496
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway.
Gu Y; Huang K; Zhang M; Teng F; Ge L; Zhou J; Xu J; Jia X
Cancer Biother Radiopharm; 2022 Sep; 37(7):580-588. PubMed ID: 34242057
[No Abstract] [Full Text] [Related]
4. STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/
Xie M; Fu Q; Wang PP; Cui YL
Dis Markers; 2021; 2021():1405045. PubMed ID: 34790276
[TBL] [Abstract][Full Text] [Related]
5. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
[TBL] [Abstract][Full Text] [Related]
6. RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.
Yu X; Zhao P; Luo Q; Wu X; Wang Y; Nan Y; Liu S; Gao W; Li B; Liu Z; Cui Z
Oncogene; 2024 Feb; 43(6):420-433. PubMed ID: 38092960
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
8. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.
Du W; Feng Z; Sun Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):198-202. PubMed ID: 30442370
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
11. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
Xu QF; Tang YX; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway.
Xu Y; Lu J; Lou N; Lu W; Xu J; Jiang H; Ye G
Pathol Res Pract; 2022 May; 233():153856. PubMed ID: 35366462
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
17. Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p Axis.
Yu Z; Wang Y; Wang B; Zhai J
Cancer Biother Radiopharm; 2022 Nov; 37(9):792-801. PubMed ID: 32522016
[No Abstract] [Full Text] [Related]
18. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
19. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA (LncRNA) SNHG7/ Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant.
Zhang J; Zhang R; Ye Y
Bioengineered; 2021 Dec; 12(2):10541-10552. PubMed ID: 34709112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
